Free Trial of Humanized Animal Models – 5 Free Humanized KnockIn Mice Offer!
This promotion has ended, please check out our Humanized Animal Models and Cell lines instead. New Year. New Research Opportunities. Our Therapeutic Focus Biocytogen's…
Read moreBiocytogen Establishes Two Business Divisions to Distinguish Preclinical Models and Services (BioMice) From Antibody Drug R&D
Beijing, China, August 31, 2023 – Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announces the official formation of two major business divisions to…
Read moreEucure and Syncromune Establish Technology Transfer Agreement for YH002 (OX40 Antibody) and Multiple Other Clinical-Stage Antibodies
BEIJING, China, August 30, 2023 – Eucure (Beijing) Biopharma Co., Ltd. (“Eucure”), a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”), announced today…
Read moreMeet Us at Our Booth in JCA2023!
Biocytogen’s Asia-Pacific business development team is pleased to exhibit at the 82nd annual meeting of the Japanese cancer association, taking place from September 21–23, 2023…
Read moreBiocytogen’s Project Integrum Achieves Milestone Progress, Accelerating Antibody Business Growth
BEIJING, China--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced today that its Project Integrum has completed 2 core milestones, and its antibody business is…
Read moreBiocytogen Announces Grand Opening of Waltham, MA Facility
State-of-the-Art Facility Signifies Growth of Business in North America and Europe August 16, 2023, Waltham, MA & Beijing, China - Biocytogen Pharmaceuticals (HKEX: 02315; “Biocytogen”),…
Read moreWebinar: Overcoming Difficulties In GPCR Antibody Discovery Using Biocytogen’s Renmice-Based Platform
Our webinar “Overcoming Difficulties In GPCR Antibody Discovery Using Biocytogen's Renmice-Based Platform" was live at 11:00 AM EDT on Aug 30th, 2023. About the Webinar GPCRs…
Read moreJoin us at the 11th Annual Immuno-Oncology Summit: Aug 7-9
Join us at the 11th Annual Immuno-Oncology Summit from August 7-9 in Boston! Learn more about our in vivo efficacy, PK/PD, toxicity, and in vitro…
Read moreJoin us at Basic Cardiovascular Sciences Scientific Sessions 2023: July 31–August 3
Join us at the Basic Cardiovascular Science Event from July 31-August 3 in Boston! Learn more about how our gene editing services and animal models…
Read moreMeet us at BIO Asia-Taiwan!
Biocytogen’s Asia-Pacific business development team is pleased to host online 1-on-1 meetings at BIO Asia-Taiwan, taking place from July 25-26, 2023! Chat with our team…
Read more